https://www.sciencedaily.com/releases/2015/03/150316102028.htm
Patients taking evolocumab -- an investigational therapy previously shown to dramatically lower 'bad' cholesterol -- were half as likely to die, suffer a heart...
after one yearnew drugevolocumabcholesterolpatients
https://www.cbsnews.com/pittsburgh/news/port-authority-2022-fare-changes/
Transit fares will be a bit different in 2022. The Port Authority board approved some fare changes Friday.
port authoritystandard farefor allboardmakes